CEMP Insider Trading Activity and SEC Form 4 Filings
CEMP insider trading summary
No open-market insider purchases or sales of Cempra, Inc. (CEMP) have been reported on SEC Form 4 in the past 12 months.
Latest CEMP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 8, 2017 | Dov A Md Goldstein | Director | Sell | $356K (99,900 @ $3.57) |
| Mar 7, 2017 | Dov A Md Goldstein | Director | Sell | $177K (50,100 @ $3.53) |
| Jan 13, 2017 | Dov A Md Goldstein | Director | Sell | $359K (105,460 @ $3.40) |
| Jan 6, 2017 | Dov A Md Goldstein | Director | Sell | $1.6M (437,600 @ $3.64) |
| Jan 5, 2017 | Dov A Md Goldstein | Director | Sell | $1.6M (500,000 @ $3.20) |
| Jan 3, 2017 | David N Gill | Director | Buy | $15K (5,000 @ $2.94) |
| Mar 1, 2016 | David Moore | Chief Commercial Officer | Buy | $8K (500 @ $16.18) |
| Jan 4, 2016 | Dov A Md Goldstein | Director | Sell | $25K (842 @ $30.06) |
| Dec 15, 2015 | David W. Oldach | Chief Medical Officer | Sell | $53K (1,778 @ $30.00) |
| Dec 11, 2015 | David W. Oldach | Chief Medical Officer | Sell | $249K (8,222 @ $30.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.